New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
05:59 EDTAGN, WFMStocks with implied volatility below IV index mean; AGN WFM
Stocks with implied volatility below IV index mean; Allergan (AGN) 27, Whole Foods (WFM) 22 according to iVolatility.
News For AGN;WFM From The Last 14 Days
Check below for free stories on AGN;WFM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
July 16, 2014
08:16 EDTAGNLew's letter could bring 'chilly' tax inversion environment, says BMO Capital
Subscribe for More Information
07:59 EDTAGNTreasury Secretary urges Congress to take action on tax inversions
Subscribe for More Information
05:53 EDTWFMWhole Foods implied volatility of 42 at upper end of index mean range
Subscribe for More Information
July 15, 2014
11:13 EDTAGNPerrigo retreats after analyst sees limited potential buyers
Subscribe for More Information
06:05 EDTWFMWhole Foods implied volatility of 40 at upper end of index mean range
Subscribe for More Information
July 14, 2014
12:47 EDTAGNAllergan slides question Valeant growth, disclosures, says BMO Capital
Subscribe for More Information
08:13 EDTAGNAllergan reiterates belief that Valeant model unsustainable in new presentation
Subscribe for More Information
08:02 EDTAGNValeant submits HSR filing for proposed acquisition of Allergan
Subscribe for More Information
July 13, 2014
15:54 EDTWFMGameStop, TJX, Staples, three other retailers look cheap, Barron's says
Subscribe for More Information
July 11, 2014
16:48 EDTAGNAllergan comments on Pershing Square’s definitive proxy solicitation
Allergan (AGN) provided the following comment in response to the definitive proxy solicitation filed by Pershing Square Capital Management in connection with Pershing Square’s request to call a Special Meeting of Stockholders. At the Special Meeting, if called, Allergan stockholders would be asked to remove a majority of the company’s existing directors in connection with Valeant Pharmaceuticals' (VRX) unsolicited exchange offer to acquire all outstanding common shares of Allergan for 0.83 shares of Valeant common stock and $72.00 in cash, or subject to proration, an amount of cash or a number of Valeant common shares with the implied value set forth in the exchange offer. Under the current Board’s leadership, which includes individuals with significantly more industry experience than Pershing Square’s recommended nominees, Allergan continues to execute on its plan to drive near- and long-term organic growth, enhance its growth prospects and continue generating significant value for all of Allergan’s stockholders. We believe Pershing Square’s attempt to replace a majority of the Allergan Board is a further effort to support Valeant in its bid to acquire Allergan at a grossly inadequate price that substantially undervalues the company and creates significant risks and uncertainties for Allergan stockholders. Valeant has repeatedly failed to address the serious concerns raised by Allergan and important members of the investment community about Valeant’s anemic organic growth driven by unsustainable price increases, among other fundamental business model issues. Allergan has a track record of consistently acting in the best interests of its stockholders and the Board remains confident in the company’s ability to create significantly more value than Valeant’s proposal.
11:54 EDTAGNAbbVie, Shire in active takeover talks, Bloomberg reports
AbbVie (ABBV) and Shire (SHPG) are in active talks about a potential merger after AbbVie raised its takeover offer for a fourth time, Bloomberg reports, citing people with knowledge of the matter. The talks are in the early stage and may not lead to an agreement, sources told Bloomberg. Shares of Shire are up 5%, or $12.04, to $250.65 following the report.
11:45 EDTWFMStocks with call strike movement; YHOO WFM
Subscribe for More Information
July 10, 2014
08:53 EDTWFMWhole Foods 2H comps guidance may be too high, says Cantor
Cantor remains concerned about the effects of competitive pricing pressure on Whole Foods. The firm thinks the company could face execution challenges going forward, and it believes that the company's multiple remains too high, given its challenges. The firm cut its price target on the shares to $34 from $38 and keeps a Sell rating on the stock.
July 9, 2014
18:31 EDTAGNShareholders urge Allergan to make large acquisition, FT reports
Subscribe for More Information
18:21 EDTAGNAllergan CEO seeks sizeable acquisitions, WSJ reports
Subscribe for More Information
06:19 EDTAGNAllergan plans broad restructuring plan, Bloomberg says
Allergan (AGN), the pharmaceutical maker that is being chased by Valeant (VRX) and Bill Ackman’s hedge fund, will shelve unpromising pipeline medicines and revamp management incentives, according to Bloomberg, citing two people with knowledge of the matter. The sources said that the restructuring plan, which is set to be explained during Allergan's upcoming earnings announcement, will also detail companywide cost reductions including some legacy expenses. Reference Link
06:06 EDTWFMWhole Foods implied volatility of 41 at upper end of index mean range
July 8, 2014
18:49 EDTWFMWhole Foods recalls two pre-packaged salads in Northeast, AP reports
As a result of a mislabeling of allergens, Whole Foods is recalling two pre-packaged salads sold in three northeastern states, AP reports. Reference Link
12:45 EDTWFMThe Fresh Market sinks after Goldman downgrade to Sell
Subscribe for More Information
06:15 EDTWFMWhole Foods implied volatility of 40 at upper end of index mean range
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use